Oncogenic KRAS is not necessary for Wnt signalling activation in APC-associated FAP adenomas
about
Molecular approach to genetic and epigenetic pathogenesis of early-onset colorectal cancerWnt signalling in adenomas of familial adenomatous polyposis patients.Updating the Wnt pathways.Oncogenic KRAS signalling promotes the Wnt/β-catenin pathway through LRP6 in colorectal cancer.DDX3 promotes tumor invasion in colorectal cancer via the CK1ε/Dvl2 axis.Evidence for possible non-canonical pathway(s) driven early-onset colorectal cancer in India.ROS production and NF-κB activation triggered by RAC1 facilitate WNT-driven intestinal stem cell proliferation and colorectal cancer initiation.DDX3 enhances oncogenic KRAS‑induced tumor invasion in colorectal cancer via the β‑catenin/ZEB1 axis.Chemical inhibition reveals differential requirements of signaling pathways in krasV12- and Myc-induced liver tumors in transgenic zebrafish.Mechanisms of RAS/β-catenin interactions.Hypoxia mimetic deferoxamine influences the expression of histone acetylation- and DNA methylation-associated genes in osteoblasts.Oxidative DNA damage drives carcinogenesis in MUTYH-associated-polyposis by specific mutations of mitochondrial and MAPK genes.Chemoprevention with Cyclooxygenase and Epidermal Growth Factor Receptor Inhibitors in Familial Adenomatous Polyposis Patients: mRNA Signatures of Duodenal Neoplasia.The canonical way to make a heart: β-catenin and plakoglobin in heart development and remodeling.
P2860
Q26769935-9027A5DD-98C9-49B5-9F0A-4DBD8A94FCC9Q34253633-EF915D02-5ECE-4D1B-9664-A6FF274A71E8Q34360489-A123CE3A-9B31-442A-90F9-D195E128B47CQ36394050-54E5B78A-DE30-4AAF-99EC-CDD2E0918798Q36595592-B8AF9B51-E570-4DED-864C-9A57D4EACCF0Q36685016-5EF01897-B25E-472F-B7C5-9A8AC3AD1FD5Q36949354-7B57E728-E0A1-46D1-B9FA-7398E7997D6AQ37225645-FF29971D-162D-4D41-A6AB-EEF7B5B183BAQ37738003-2EF044FD-6B32-4899-9867-FE9DFF77E166Q38088654-36F28D73-6C02-4579-8CB9-A32694A97AE4Q38910456-74DD1C8E-5E5C-4D32-AD78-23BF3AD978A6Q45894756-5EF071B6-D73D-4C95-86C1-A0AD6BAC757DQ47647134-0FAA2E0D-EEFA-449C-B8FC-4B47BD14C68DQ47787830-BC25A7FD-7767-4DB8-B02D-4C6B857DE946
P2860
Oncogenic KRAS is not necessary for Wnt signalling activation in APC-associated FAP adenomas
description
im Januar 2010 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 May 2010
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в січні 2010
@uk
name
Oncogenic KRAS is not necessar ...... in APC-associated FAP adenomas
@en
Oncogenic KRAS is not necessar ...... in APC-associated FAP adenomas
@nl
type
label
Oncogenic KRAS is not necessar ...... in APC-associated FAP adenomas
@en
Oncogenic KRAS is not necessar ...... in APC-associated FAP adenomas
@nl
prefLabel
Oncogenic KRAS is not necessar ...... in APC-associated FAP adenomas
@en
Oncogenic KRAS is not necessar ...... in APC-associated FAP adenomas
@nl
P2093
P2860
P50
P356
P1476
Oncogenic KRAS is not necessar ...... in APC-associated FAP adenomas
@en
P2093
Antònia Obrador-Hevia
Joel K Greenson
Jonathan Rees
Sara González
P2860
P356
10.1002/PATH.2685
P577
2010-05-01T00:00:00Z